These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 22854528)
1. Innovative technologies for SFA occlusions: drug coated balloons in SFA lesions. Minar E; Schillinger M J Cardiovasc Surg (Torino); 2012 Aug; 53(4):481-6. PubMed ID: 22854528 [TBL] [Abstract][Full Text] [Related]
2. Randomized trial of Legflow(®) paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial. Karimi A; de Boer SW; van den Heuvel DA; Fioole B; Vroegindeweij D; Heyligers JM; Lohle PN; Elgersma O; Nolthenius RP; Vos JA; de Vries JP Trials; 2013 Mar; 14():87. PubMed ID: 23537403 [TBL] [Abstract][Full Text] [Related]
3. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582 [TBL] [Abstract][Full Text] [Related]
4. Standard balloon angioplasty versus angioplasty with paclitaxel-eluting balloons for femoropopliteal artery stenosis. Ju MH; Rodríguez HE J Cardiovasc Surg (Torino); 2012 Aug; 53(4):459-63. PubMed ID: 22854525 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. Micari A; Cioppa A; Vadalà G; Castriota F; Liso A; Marchese A; Grattoni C; Pantaleo P; Cremonesi A; Rubino P; Biamino G JACC Cardiovasc Interv; 2012 Mar; 5(3):331-8. PubMed ID: 22440500 [TBL] [Abstract][Full Text] [Related]
12. A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm results. Micari A; Cioppa A; Vadalà G; Stabile E; Castriota F; Pantaleo P; Grattoni C; Cremonesi A; Marchese A; Rubino P; Biamino G EuroIntervention; 2011 May; 7 Suppl K():K77-82. PubMed ID: 22027734 [TBL] [Abstract][Full Text] [Related]
13. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis. Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133 [TBL] [Abstract][Full Text] [Related]
14. How should I treat a restenosis after superficial femoral artery stenting? Fusaro M; Cassese S; Byrne RA EuroIntervention; 2013 Mar; 8(11):1342-5. PubMed ID: 23538161 [No Abstract] [Full Text] [Related]
15. Paclitaxel-coated versus plain old balloon angioplasty for the treatment of infrainguinal arterial disease in diabetic patients: the Belgian diabetic IN.PACT Trial. Debing E; Aerden D; Vanhulle A; Gallala S; von Kemp K; J Cardiovasc Surg (Torino); 2017 Aug; 58(4):528-534. PubMed ID: 27727202 [TBL] [Abstract][Full Text] [Related]
17. Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon. Thomas SD; McDonald RR; Varcoe RL J Vasc Surg; 2014 Feb; 59(2):520-3. PubMed ID: 23642919 [TBL] [Abstract][Full Text] [Related]
18. Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date. Barkat M; Torella F; Antoniou GA Vasc Health Risk Manag; 2016; 12():199-208. PubMed ID: 27274265 [TBL] [Abstract][Full Text] [Related]
19. Prime time for drug eluting balloons in SFA interventions? Brodmann M J Cardiovasc Surg (Torino); 2014 Aug; 55(4):461-4. PubMed ID: 24941235 [TBL] [Abstract][Full Text] [Related]